Apple's health tech takes early lead among top hospitals
10 February 2015
Apple Inc's (AAPL.O) healthcare technology is spreading quickly among major U.S. hospitals, showing early promise as a way for doctors to monitor patients remotely and lower costs.
Low rates, M&A spur flood of pharma debt deals
09 February 2015
Merck & Co's US$8bn jumbo bond is just the tip of the iceberg of debt supply from the healthcare sector in the months ahead with brand names like Novartis and Pfizer set to compete for investor cash.
Researchers develop low-cost smartphone device for quick HIV and syphilis screening
09 February 2015
As devicemakers home in on cheap, rapid diagnostics for patients in developing nations, researchers are creating a low-cost smartphone device to quickly test for infectious diseases in poor countries.
Novo investing $750M in manufacturing this year
06 February 2015
Novo Nordisk ($NVO) has an insulin plant that will open soon in Russia and bought a plant from Olympus Biologics in the U.S. last year where it will make active pharmaceutical ingredients (APIs). These projects are part of efforts by the Denmark-based leader in insulin drugs to build its manufacturing capacity as it continues to grow.
Two new med tech incubators in the works--one with the AMA, the other Georgia Tech
06 February 2015
Early med tech innovation may get a bit of a boost with two new incubators. The American Medical Association is partnering with Chicago-based healthcare technology incubator Matter. The pair will create AMA Interaction Studio at Matter, a physical and virtual infrastructure for entrepreneurs and physicians to collaborate to develop new healthcare tech, services and products.
Precision Medicine Initiative focuses on genomics, data sharing, health IT
06 February 2015
Not nearly as expansive as the draft 21st Century Cures Initiative released earlier last week by a House committee, the president Friday unveiled his $215 million Precision Medicine Initiative focusing on collaborative efforts to leverage advances in genomics, data sharing and health information technology to accelerate biomedical discoveries.
FDA Encourages Supplements for Oncology Drug
05 February 2015
One way to reduce off-label prescribing of treatments for cancer and other conditions is for manufacturers to test additional indications and file supplemental applications to add those uses to approved labeling. The problem is that the testing and approval process for supplements takes a lot of time and money. And formal approval of new uses often is less critical in oncology where off-label prescribing is the norm.
Meeting Unmet Medical Needs: The Disparity Dilemma
05 February 2015
Although prescription drugs comprise a relatively small percentage of overall healthcare expenditures at 10%, they, nonetheless, represent the primary point-of-contact between the majority of the US population and the healthcare system; while 62% of Americans fill a prescription in any given year, only 8% typically experience a hospital stay. Thus, in an era of health reform, when a primary concern for decision-makers at all levels—policymakers, public health officials, practitioners—is how well our system is meeting the medical needs of the population, focusing on the role played by prescription drugs is essential.
India jumps into the generic drug biz to compete with commercial players on price
05 February 2015
India's government is getting into the generic drug business. The state reportedly will launch its own brand, "Jan Aushadhi," on July 1, planning to sell up to 504 drugs on its "essential" list in direct competition with commercial drugmakers. The government drugs will be available only in Jan Aushadhi-branded hospital pharmacies, and hospitals may be required to use them.
Moody's: Big Pharmas face growing patent-loss threats, but some pipelines are improving
04 February 2015
For the past couple of years, the pharma industry has had something of a reprieve from patent-cliff nightmares. But according to Moody's Investors Service, some companies face new threats to their sweet dreams.
Merry Christmas and Happy New Year!
28 December 2024
NovaMedica team in the TOP 100 INFLUENTIAL PEOPLE IN THE PHARMACEUTICAL BUSINESS 2024
28 November 2024
05 November 2024
A Moscow region manufacturer of blood collection systems is expanding its capacity
22 January 2025
A biotechnology and medicine center has opened in Mordovia
22 January 2025
Long-term potential revealed for novel modifier gene therapy
21 January 2025
Binnopharm Group opened an office in Vietnam
21 January 2025